Expanding community investment and supporting thousands of Southern Ohio jobs.
Widely repeated humanoid robot production numbers, Tesla past 50,000 Optimus units, Figure AI past 10,000 deployments, don’t come from the companies themselves. Tesla’s own 2025 target was 5,000 units for internal use; actual output was a few hundred. The gap between claimed and audited numbers is now the story investors and buyers should be pricing in.
Humanoid robot production numbers have become the least reliable statistic in industrial AI. Search for how many humanoid robots are actually working today and you’ll find confident figures everywhere: Tesla past 50,000 cumulative Optimus units, Figure AI past 10,000 deployments across partner warehouses. None of those figures come from the companies they describe, according to a July 2026 investigation by Technology.org. Tesla has never published an audited Optimus production count.
The clearest example sits in Tesla’s own record. The company targeted 5,000 Optimus units for internal factory use in 2025. Actual output, per mid-2025 reporting from The Information cited by Technology.org, was a few hundred units, under ten percent of the goal. Contributing factors included China’s April 2025 export restrictions on rare earth magnets and a longer-than-planned Gen 3 design finalization, particularly on the dexterous hand system.
Chuck Brooks is the president of Brooks Consulting International and one of Executive Mosaic’s GovCon Experts.
The United States is about to enter a new age of technical competitiveness where the rate of innovation and invention could have just as much of an impact on national security as the technology itself. Emerging technologies such as directed energy, biotechnology, autonomous systems, robotics, advanced manufacturing, artificial intelligence and quantum computing are developing concurrently and rapidly converging.
This convergence is posing a fundamental dilemma for the Department of War: Can the government organize itself to find, develop, buy and field new technology at the same rate as the business sector and America’s adversaries? A major reorganization of the Department’s research, technology and innovation ecosystem is starting to reveal the solution.
OpenAI’s new Daybreak Red tier gives approved defenders a model that completes 95% of advanced exploit-development requests, versus roughly 2% for the public version of the same base model. That gap is now the real story: AI cybersecurity access tiers decide who gets frontier defensive power and who doesn’t, and access runs through a partner list, not a price tag.
AI cybersecurity access tiers stopped being a theoretical debate this month. OpenAI expanded its Daybreak program into two levels, Blue and Red, and released GPT-5.6-Cyber, a specialized model built specifically for vulnerability research and exploit-chain development, according to SecurityBrief’s coverage of the launch. In an internal OpenAI evaluation, the new model completed 95.0% of advanced cyber requests covering authentication bypass, privilege escalation, and exploit-chain development, compared with 1.5% for the general-release model and 2.0% for that same model through the safeguarded Daybreak Blue tier.
GPT-5.6-Cyber is only available through Daybreak Red, gated behind identity verification, monitoring, legal attestations, and approved-use restrictions, per Cyberpress’s reporting. Under OpenAI’s own Preparedness Framework, the model was rated “High” for cybersecurity capability, one step below the “Critical” threshold that recently triggered an internal suspension of a different unreleased model, Astra, on August 7. These AI cybersecurity access tiers exist because the underlying capability is real: a general-purpose model built to refuse exploit-writing requests is far less useful to a security team validating a patch than one built to complete them.
Meta’s AI codec was used for the compression.
Here is an interesting AI video called “”. (It is not an adult-only video.)
Outside it’s hot. Inside it’s STEAMY.
Aubrey de Grey believes ageing is accumulated damage in a biological machine and argues that medicine may eventually become capable of repairing that damage faster than it appears. He gives humanity a 50/50 chance of reaching what he calls “longevity escape velocity” within the next 12–15 years.
Peter and Aubrey discuss why the body ages, the seven categories of damage that must be repaired, stem-cell and gene therapies, the mouse experiment that could transform the field and why Aubrey believes rejuvenation treatment will ultimately be available to everyone rather than reserved for the wealthy.
They also explore what happens to population, work, fertility, relationships, religion and the meaning of life if people stop getting sick from ageing. Aubrey explains why AI cannot replace the missing biological experiments, why longevity research remains so difficult to fund, and why he is driven by the 110,000 people he says die from ageing-related causes every day.
TIMESTAMPS:
00:00:00 — Trailer.
00:00:48 — Can We Cure Ageing?
00:04:24 — The 12–15 Year Prediction.
00:06:17 — The Body Is a Machine.
00:15:21 — How Aubrey Entered Longevity.
00:18:45 — Would You Want to Live Forever?
00:20:15 — Does Longevity Change Risk?
00:21:53 — Will Population Explode?
00:24:22 — Can You Choose Your Age?
00:30:19 — The Seven Types of Ageing Damage.
00:36:54 — What Rejuvenation Treatment Looks Like.
00:45:35 — Will It Be Expensive?
00:48:39 — Who Would Refuse It?
00:53:00 — Why Longevity Research Lacks Funding.
00:56:02 — The Mouse Experiment.
01:00:18 — The Breakthrough That Changes Everything.
01:01:35 — Does Death Give Life Meaning?
01:05:22 — Bryan Johnson and AI
01:12:32 — AlphaFold, AGI and AI Risk.
01:15:13 — Why Funding Is So Hard.
CONTACT PETE:
› Website – https://www.petermccormack.com/
› Feedback – https://www.petermccormack.com/contact.
› Email – [email protected].
› Instagram – / mccormack555
› X/Twitter – https://twitter.com/petermccormack/
CONNECT WITH AUBREY DE GREY:
Because adding a quick instruction to an AI’s guide file is fast and low-risk, developers continually tack on new rules whenever the AI makes a mistake (e.g., “Don’t use library X,” or “Always run tests with flag Y”). Over time, however, the original context and reasoning behind older instructions fade from human memory.
Agent instruction files like CLAUDE.md exhibit unbounded growth due to “catastrophic remembering,” a process where the original rationale for instructions is lost, making safe deletion difficult…